Cargando…

NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial

SIMPLE SUMMARY: A hepatocellular carcinoma (HCC) is the most common cause of death in patients suffering from chronic liver diseases. In order to improve the prediction of outcomes in HCC patients, there is a need for new biomarkers. This pilot study aimed at identifying serum metabolites for the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geyer, Thomas, Rübenthaler, Johannes, Alunni-Fabbroni, Marianna, Schinner, Regina, Weber, Sabine, Mayerle, Julia, Schiffer, Eric, Höckner, Sebastian, Malfertheiner, Peter, Ricke, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199928/ https://www.ncbi.nlm.nih.gov/pubmed/34205110 http://dx.doi.org/10.3390/cancers13112787

Ejemplares similares

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2019)

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial
por: Shuen, Timothy Wai Ho, et al.
Publicado: (2022)

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
por: Seidensticker, Max, et al.
Publicado: (2023)

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy
por: Stechele, Matthias, et al.
Publicado: (2023)

Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
por: Surov, Alexey, et al.
Publicado: (2023)

Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2022)

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
por: Öcal, Osman, et al.
Publicado: (2022)

Measuring HCC Tumor Size in MRI—The Sequence Matters!
por: Armbruster, Marco, et al.
Publicado: (2021)

Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer
por: Kästle, Sophia, et al.
Publicado: (2023)

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Early monocyte response following local ablation in hepatocellular carcinoma
por: Kimm, Melanie A., et al.
Publicado: (2022)

Reproducibility of CT-Based Hepatocellular Carcinoma Radiomic Features across Different Contrast Imaging Phases: A Proof of Concept on SORAMIC Trial Data
por: Ibrahim, Abdalla, et al.
Publicado: (2021)

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
por: Schütte, Kerstin, et al.
Publicado: (2014)

Tumor-Associated Macrophages—Implications for Molecular Oncology and Imaging
por: Kimm, Melanie A., et al.
Publicado: (2021)

Obesity After Kidney Transplantation—Results of a KTx360°Substudy
por: Nöhre, Mariel, et al.
Publicado: (2020)

Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor–PET/CT
por: Ingenerf, Maria, et al.
Publicado: (2023)

Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort
por: Seidensticker, Max, et al.
Publicado: (2022)

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021)

Prevalence of Mental Disorders in a German Kidney Transplant Population: Results of a KTx360°-Substudy
por: Birkefeld, Katrin, et al.
Publicado: (2022)

Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study
por: De Toni, Enrico N, et al.
Publicado: (2020)

Prevalence and Correlates of Cognitive Impairment in Kidney Transplant Patients Using the DemTect—Results of a KTx360 Substudy
por: Nöhre, Mariel, et al.
Publicado: (2019)

Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
por: Kdadra, Marouane, et al.
Publicado: (2019)

Knowledge About Immunosuppressant Medication and Its Correlates in a German Kidney Transplant Population – Results of a KTx360° Substudy
por: de Boer, Sophie, et al.
Publicado: (2020)

A high-throughput DNA methylation analysis of a single cell
por: Kantlehner, Martin, et al.
Publicado: (2011)

Structured Reporting Using CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma (HCC)—Impact and Advantages on Report Integrity, Quality and Interdisciplinary Communication
por: Geyer, Thomas, et al.
Publicado: (2021)

The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond
por: Schulz, Christian, et al.
Publicado: (2019)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Characterization of Salivary and Plasma Metabolites as Biomarkers for HCC: A Pilot Study
por: Hershberger, Courtney E., et al.
Publicado: (2023)

rNMR: open source software for identifying and quantifying metabolites in NMR spectra
por: Lewis, Ian A, et al.
Publicado: (2009)

Comparative Response of HCC Cells to TKIs: Modified in vitro Testing and Descriptive Expression Analysis
por: Sagmeister, Paula, et al.
Publicado: (2022)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience
por: Walter, Franziska, et al.
Publicado: (2021)

Untargeted NMR-Based Methodology in the Study of Fruit Metabolites
por: Sobolev, Anatoly Petrovich, et al.
Publicado: (2015)

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving (90)Y-radioembolization
por: Hirner-Eppeneder, Heidrun, et al.
Publicado: (2023)

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy
por: Martin, Mickaël, et al.
Publicado: (2017)

Serum Myo-Inositol, Dimethyl Sulfone, and Valine in Combination with Creatinine Allow Accurate Assessment of Renal Insufficiency—A Proof of Concept
por: Ehrich, Jochen, et al.
Publicado: (2021)

Evaluation of the Diagnostic Value of Contrast-Enhanced Voiding Urosonography with Regard to the Further Therapy Regime and Patient Outcome—A Single-Center Experience in an Interdisciplinary Uroradiological Setting
por: Marschner, Constantin A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1dkje1nui3kbmhfjgh0k3c92n9